EBRETORK
Live / Allowed — Published for opposition (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99417742
- Mark type
- Stylized text
- Filed
- 29 Sept 2025
- Published for opposition
- 03 Mar 2026
- Attorney of record
- Lisa Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
Owner
- Merck Sharp & Dohme LLC, Rahway, NJ, US
- Merck Sharp & Dohme LLC, Rahway, NJ, US
Prosecution history
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Feb 2026 — ASSIGNED TO EXAMINER
- 29 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Sept 2025 — NEW APPLICATION ENTERED